Quality Specifications for B-Type Natriuretic Peptide Assays | Zendy

Fred S. Apple | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quality Specifications for B-Type Natriuretic Peptide Assays

Author(s) -

Fred S. Apple

Publication year - 2005

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2004.044594

Subject(s) - natriuretic peptide , medicine , food and drug administration , biomarker , quality (philosophy) , clinical trial , intensive care medicine , medical physics , pharmacology , heart failure , biochemistry , chemistry , philosophy , epistemology

The objective of this report is to improve the quality of immunochemical measurements of B-type natriuretic peptide (BNP) and its N-terminal propeptide (NT-proBNP). The recommendations proposed are intended for use by manufacturers of commercial assays, by clinical laboratories using those assays, by clinical trial groups and research investigators, and by regulatory agencies, such as the United States Food and Drug Administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research